16
Chapter 415: The Next-Generation Vessel
Ikeizumi had his back to him, adjusting the temperature in front of the water bath, with his cane leaning against the edge of the workbench.
The weight-bearing posture of his right leg was more natural than during any previous rehabilitation period.
"After you finish making that awakening agent, the first practical combat test will be done by me," Guy said.
Ikeizumi did not turn around.
"Provided that your ribs are completely healed before the practical combat test.
Otherwise, I will give the test qualification to a Jonin who has just finished meniscus surgery—at least his meniscus healing cycle is shorter than his ribs."
Guy snorted at the door.
It was not a laugh, but that kind of sound expelled from the nasal cavity, somewhere between unconvinced and acknowledgement.
Then he walked out, his hand resting briefly against the wall of the corridor.
It wasn't that he needed support, but rather that he was used to patting the wall with his palm at corners—a habit he had practiced for over a decade in the training ground, which he couldn't break even in the corridor.
By the third week, Akamatsu Kinpei's antibody gene sequence was finally fully analyzed.
Ikeizumi guarded the gene sequencer for two whole days.
The sequencer was an older capillary electrophoresis machine that had been out of use for several years.
When dragged out from the special equipment warehouse of the Research Institute, the chassis had accumulated a thick layer of dust.
Shizune helped blow away the dust with a compressed air can, replaced two new capillaries, calibrated the laser detector, and fussed over it for three days before getting the old machine running again.
When the sequencing results appeared on Ikeizumi's computer screen, he was drinking his fourth cup of tea of the day.
The tea had gone cold, and the tea grounds had settled at the bottom of the cup.
He took a sip of cold tea, spat the grounds back into the cup, and stared intently at the long string of ATCG sequences on the screen.
The sequence was longer than he had estimated—the heavy chain variable region gene of Akamatsu Kinpei's specific antibody consisted of 3,400 base pairs, which was nearly three times that of ordinary human antibody heavy chain variable regions.
After the extra portion of the sequence was translated into a protein, it would form an additional ring-like structure at the antigen-binding site of the antibody—a ring-like structure that ordinary antibodies did not have.
Its amino acid sequence formed a perfect complementarity with a glycoprotein on the surface of the Divine Tree cells.
"Lock and key," Ikeizumi muttered to himself facing the screen, "the surface glycoprotein structure of the Divine Tree cell is a lock, and Akamatsu Kinpei's immune system, under three years of continuous low-intensity stimulation, forcefully polished out a perfect key."
He exported the sequence data and began designing the cloning protocol.
The first step of antibody gene cloning was to insert this 3,400-base-pair sequence into an expression vector, and then transfer the vector into host cells—usually Escherichia coli or yeast—allowing the host cells to multiply massively in culture tanks while mass-producing antibody proteins.
This process sounded simple, but in actual operation, every step had traps.
Gene fragments with sequences that were too long were prone to breaking when inserted into the vector, and if they broke, they had to be done all over again.
When expressing human antibody proteins, host cells might fold the protein into the wrong shape; if folded incorrectly, the antibody would have no activity and would just be a tube of useless protein solution.
Ikeizumi listed a problem checklist in his experimental logbook.
The checklist listed six problems, each of which was a technical difficulty he anticipated encountering during the cloning process.
He tore off the checklist and pasted it on the side of the incubator, then began solving them one by one.
The first problem was solved on the fourth day.
The second problem on the seventh day.
The third problem got stuck for nearly a week—the antibody proteins expressed by the host cells were indeed folded incorrectly, and Ikeizumi performed refolding experiments under different conditions for seven consecutive days, finding the correct buffer formula on the afternoon of the fifteenth day.
When he wrote down the conditions for successful refolding in his experimental logbook, his right index finger trembled slightly, and the tip of the pen drew an extra ink mark about one centimeter long on the paper.
He looked at the ink mark, switched the pen to his left hand, and wrote it again.
The time it took to solve the fourth, fifth, and sixth problems totaled three weeks.
By the end of the sixth week, the yeast in the culture tank had multiplied to maximum density in the medium, and the color of the fermentation broth changed from light yellow to milky white.
Ikeizumi purified the first batch of awakening agent stock solution from the fermentation broth—a total volume of about twenty milliliters, transparent in color, gleaming with an extremely faint blue fluorescence under the light, with a texture slightly more viscous than water.
He dispensed the stock solution into twenty one-milliliter sealed ampoules.
The ampoules lined up under the lights of the testing department, the blue fluorescence flowing inside the glass tubes like short, severed pieces of living moonlight.
On Wednesday of the seventh week, Guy's rib X-ray showed that the bone fracture line had completely disappeared.
Tsunade signed the review report, and the recovery order read "Light taijutsu training is allowed to resume, high-intensity impact training continues to be prohibited for two weeks".
Guy folded the recovery order into three folds and tucked it into the inner pocket of his tights, entering the training ground at ten in the morning; when Ikeizumi passed by the training ground at four in the afternoon, he was still inside.
Ikeizumi stood at the edge of the training ground and watched for a while.
Guy was hitting the wooden stake, not with his fists, but with his palms—palm force was more dispersed than fist force, inflicting a slightly smaller impact on his ribs, but the frequency with which he struck with his palms remained just as steady.
The sound interval of each palm strike hitting the wooden stake was completely identical, and the rhythm was completely synchronized with his breathing.
Ikeizumi did not call out to him, watching for a moment before continuing to walk toward the Research Institute with his cane.
The rhythm tapped out by the cane on the sandy dirt road was exactly the same as Guy's palm-striking frequency—not intentionally, but rather because after spending so much time together underground in Zhiyu Valley, in the Bamboo Forest, and in the caves of Nameless Island, their bodily rhythms had unconsciously calibrated to each other.
At the entrance of the special equipment warehouse of the Research Institute, the technical liaison sent by Orochimaru had already arrived.
The liaison was not Orochimaru himself; Tsunade had not approved Orochimaru to be present in person, only approving him to provide technical advice through an intermediary.
The liaison was a young researcher wearing round-framed glasses, his hair tied into a low ponytail, speaking in a very soft voice.
When introducing himself, he said his name was "Mitsuki"—the current head researcher of Orochimaru's laboratory.
"Lord Orochimaru has looked at the antibody gene sequence analysis report you sent," Mitsuki stood beside the gene synthesizer.
Ikeizumi noticed that the way he spoke was somewhat different from ordinary researchers—not cold, but a way of speaking that conveyed the maximum amount of information with the fewest words.
Every sentence was packed with substance without any nonsense, "He said your refolding protocol has an extra step in the third step.
The retention time of the stock solution in the pH buffer does not need thirty minutes—you used the standard protein refolding schedule, but the ring-like structure of the Divine Tree cell antibody folds five times faster than ordinary antibodies in an acidic environment.
Within your thirty minutes of retention time, the antibody has already completed correct folding in the buffer for twenty-five minutes, and the remaining five minutes are redundant—redundant retention time will cause the already folded antibody to begin slowly denaturing in the acidic environment.
He suggests shortening the retention time of the third step to five minutes, leaving the other steps unchanged."
Ikeizumi stood in front of the synthesizer, running Orochimaru's suggestion through his mind.
His thinking was fast—within three seconds, he re-simulated every sub-step of the third step in his mind, and the simulation results were consistent with Orochimaru's suggestion.
The redundant five minutes would indeed cause trace amounts of unfolding to begin in the folded antibody protein within the acidic environment.
The proportion of unfolding was not high, about three to five percent, but accumulated to mass production scale, it would be a non-negligible loss.
"Understood." Ikeizumi opened the operating interface of the synthesizer, changing the retention time parameter of the third step from thirty minutes to five minutes, "Please convey my thanks to Orochimaru."
Mitsuki nodded without any superfluous polite remarks.
He stood aside, watching Ikeizumi restart the synthesizer, and suddenly spoke a sentence that Ikeizumi did not expect amidst the buzzing sound of the machine starting up.
"Lord Orochimaru also asked me to convey one more thing.
He said that the immunosuppressive gland culture technology used by Kabuto on Nameless Island was developed based on a set of experimental notes he left behind in a certain base before leaving the Akatsuki.
Those notes recorded the entire biosynthesis pathway of the synthesis of immunosuppressive factors, including the gene sequences and culture conditions of key enzymes.
If you need to reverse-develop an enzyme preparation capable of targeted degradation of immunosuppressive factors, Lord Orochimaru can provide a copy of those notes."
Ikeizumi's fingers paused on the touchscreen of the synthesizer.
He turned his head to look at Mitsuki.
Mitsuki's eyes behind the lenses were as calm as a pool of stagnant water, containing no information that could be used to judge whether these words were goodwill or a trap.
"What are the conditions?" Ikeizumi asked.
He had been dealing with snakes for quite some time—Orochimaru could actively offer help while under residential surveillance in Konoha, but it was impossible without any conditions.
"There are two conditions.
First, the copy of the notes is provided only for Ikeizumi's personal use, and must not be entered into the public database of the Konoha Research Institute.
Second—" Mitsuki paused, "If one day in the future, an irreconcilable conflict occurs between Konoha and some external force due to technologies related to Divine Tree cells, Lord Orochimaru hopes that Konoha will listen to his opinion at least once before deciding its final stance."
Ikeizumi looked at Mitsuki and did not answer immediately.
The synthesizer emitted a steady running sound behind him, and the progress bar on the display screen moved forward slowly.
One of the fluorescent lamp tubes on the ceiling of the warehouse was broken and kept flickering.
The alternating light and dark illumination shone on Mitsuki's face, making his expression look sincere when it lit up, and like a messenger who knew nothing and was only passing words for someone else when it darkened.
"I can make the decision on the first condition.
For the second, I need to ask Lady Tsunade for instructions," Ikeizumi said.
"Of." Mitsuki slightly bowed, then placed a kraft paper envelope sealed with wax on the workbench, "The copy of the notes is here.
Lord Orochimaru said, regardless of whether Lady Tsunade agrees to the second condition, this set of notes is given to you first.
Because if Kabuto's next vessel truly realizes the internalization of immunosuppression, the ones who die will not just be Konoha people.
Lord Orochimaru does not like others touching his research field—Divine Tree cells were something he began researching first.
Kabuto is a thief.
He hates thieves even more."
Mitsuki finished speaking and left.
His footsteps were very light, his canvas shoes making almost no sound when stepping on the plastic floor of the Research Institute corridor.
Ikeizumi picked up the kraft paper envelope on the workbench.
The wax seal of the envelope was impressed with a snake-shaped seal, the snake's eyes being two extremely fine dots of red cinnabar.
He opened the envelope to reveal a thick stack of handwritten experimental notes.
The paper had already turned yellow, and some pages were stained with coffee stains and dried blood that had turned brown.
The handwriting in the notes was Orochimaru's—slender and elongated, with a slightly upward-curved arc at the ends of the strokes.
Just like his tone of voice, every stroke was telling you that the person writing was smarter than you, knew more than you, and had already figured out that you wouldn't refuse.
Ikeizumi opened the first page of the notes.
The first page depicted a molecular structure diagram of the immunosuppressive factor, and below the structure diagram, a line of words was written in red ink: "This thing was not created by me.
I merely reproduced it."
He did not use "invented"; he used "reproduced".
Ikeizumi turned this page over and began reading the subsequent biosynthesis pathways.
The contents of the notes were extremely detailed, with the gene sequence of each enzyme annotating its source and modification method, and the culture conditions precise to the tenths place of temperature and pH value.
On the last page, Orochimaru had written a paragraph in pencil.
The pencil handwriting was newer than the ink handwriting in front, and should have been added recently—
"The immunosuppressive factor culture tank used by Kabuto in Zhiyu Valley uses the No. 3 synthesis pathway in these notes of mine.
The advantage of the No. 3 pathway is high yield, and the disadvantage is that the synthesized immunosuppressive factor has poor stability and needs to be replenished every four days.
If the gland culture on Nameless Island has achieved 72 hours of continuous secretion, it means Kabuto has upgraded to the No. 5 pathway—the half-life of the immunosuppressive factor synthesized by the No. 5 pathway is three times that of No. 3, but the No. 5 pathway has a loophole that No. 3 does not have: its sensitivity to temperature is extremely high.
In an environment above forty degrees Celsius, the immunosuppressive factor synthesized by the No. 5 pathway will irreversibly lose activity.
If you can integrate this temperature condition into your awakening agent formula—I'm not sure if you can, but you should be able to—then the immunosuppression of the next-generation vessel will be like a layer of ice baking under the sun right in front of you."
Ikeizumi closed the notes and pressed his hand on the kraft paper cover.
The broken fluorescent lamp tube on the ceiling of the warehouse flashed once more.
In that flashing instant, something that would only be noticed in the darkness was reflected in Ikeizumi's eyes—not the light of Chakra, but something spontaneously generated by thinking under a state of extreme concentration, non-luminous yet perceptible, like the slight vibration of the surrounding magnetic field when an electric current passes through a wire.
He picked up his cane, stood up, stuffed the notes into the inner pocket of his coat, and walked out leaning on his cane.
The rhythm tapped out by the cane in the corridor of the Research Institute was a fraction faster than usual—not out of urgency, but because a new experimental route was automatically unfolding in his mind at a speed too fast for him to record with a pen, with every step meshing together with the previous one, like a runaway train with intact tracks accelerating madly.
